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ess: h.kramer@int.azg.Summary Background: Endoscopic ultrasonography (EUS) is a novel method for
staging of the mediastinum in lung cancer patients. The recent development of
linear scanners enables safe and accurate fine-needle aspiration (FNA) of
mediastinal and upper abdominal structures under real-time ultrasound guidance.
However, various methods and equipment for mediastinal EUS–FNA are being used
throughout the world, and a detailed description of the procedures is lacking. A
thorough description of linear EUS–FNA is needed.
Methods: A step-by-step description of the linear EUS–FNA procedure as
performed in our hospital will be provided. Ultrasonographic landmarks will be
shown on images. The procedure will be related to published literature, with a
systematic literature search.
Results: EUS–FNA is an outpatient procedure under conscious sedation. The typical
linear EUS–FNA procedure starts with examination of the retroperitoneal area. After
this, systematic scanning of the mediastinum is performed at intervals of 1–2 cm.
Abnormalities are noted, and FNA of the abnormalities can be performed. Specimens
are assessed for cellularity on-site. The entire procedure takes 45–60min.
Conclusions: EUS–FNA is minimally invasive, accurate, and fast. Anatomical areas
can be reached that are inaccessible for cervical mediastinoscopy. EUS–FNA is useful
for the staging of lung cancer or the assessment and diagnosis of abnormalities in the
posterior mediastinum.
r 2004 Elsevier Ltd. All rights reserved.4 Elsevier Ltd. All rights reserved.
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Endoscopic ultrasonography (EUS) is a novel method
for the investigation of the surroundings of the
esophagus and stomach. It is an evolving technique
for the staging of the mediastinum in lung cancer
patients. EUS can be combined with fine-needle
aspiration (FNA) to obtain cytological specimens
under direct ultrasound vision. EUS was first
performed with radial scanning endoscopes, scan-
ning 360 transaxially from the esophagus to view
the mediastinum. The development of linear
scanners enabled safe and accurate FNA because
needle insertion into a lymph node was real-time
visible. EUS–FNA has shown to be highly accurate in
the diagnosis and staging of masses and lymph
nodes related to the gastrointestinal tract.1,2
Mediastinal lymph node imaging in lung cancer with
EUS was first described in 1988, while EUS–FNA of
mediastinal lymph nodes was first reported in
1993.3,4 Operating characteristics of EUS–FNA for
mediastinal lung cancer staging seem promising and
highly accurate.5–7 However, various methods and
equipment were used for mediastinal EUS–FNA,
while only few investigators described their EU-
S–FNA procedure in detail. A more systematic
description of the procedure may be useful for
standardization, research, and teaching purposes.
We will systematically describe the EUS–FNA pro-
cedure as performed in our hospital and relate it
with literature. We will provide images of the major
ultrasonographic landmarks for the mediastinum.Methods
A step-by-step description of the EUS–FNA procedure
as performed in our hospital will be provided.
Ultrasonographic landmarks will be shown on images.
The procedure will be related to published literature.
We searched literature with PubMed for original,
peer-reviewed, full-length original articles and meta-
analyses in English. We used the following search
terms: [lung AND cancer AND staging] and [endos-
cop*], [ultraso*], [biopsy], or [punct*]. Further
exploration of literature was guided by the reference
lists in the articles found with these searches.Figure 1 Orientation of the EUS image.Results
Equipment
The EUS–FNA procedure for staging of lung cancer
will be described step-by-step, from high retro-peritoneal area to the upper mediastinum. The
locations of mediastinal lymph nodes are described
according to the mediastinal lymph node map of
Naruke, revised by Mountain and Dresler.8 A linear
ultrasound endoscope (FG-34UX, Pentax GmbH,
Hamburg, Germany) and a scanner unit (EUB-525,
Hitachi Ultrasound BV, Reeuwijk, The Netherlands)
are used. The endoscope has a 60 forward oblique
viewing video camera, a 120 scanning ultrasound
transducer with a 105 field of view, and a 2.0mm
working channel. The tip can be deflected 60 to
the left and 60 to the right, 65 upwards, and 65
downwards. A water-filled balloon may be put
around the tip to decrease ultrasound disturbance
by air. However, in our experience omission of the
balloon does not result in much more scattering,
and pressing the tip of the endoscope against the
mucosal surface gives adequate images. Therefore,
the balloon is not used anymore. Scanning fre-
quency is switchable between 5 and 7.5MHz, and
Doppler flow imaging can be used to detect blood
vessels. FNA is performed with a hollow 22 gauge
needle with a stylet (Echotips; Wilson-Cook Med-
ical Inc., Winston-Salem, USA), but other needles
can be used as well.
Linear scanning endoscopes produce images with
vertical orientation (Fig. 1). On the screen the
esophagus is the rotation axis, positioned at the top
of the image, while the bottom of the image
reflects the area most peripheral of the esophagus.
The right side of the ultrasound image is cranial and
the left side caudal, although this can be adjusted.
On ultrasound images, hypoechoic structures are
darker than the surrounding tissue, and hyper-
echoic structures are lighter than their surround-
ings. Fluids such as pleural effusion and blood are
extremely hypoechoic (black). The ultrasono-
graphic appearance of lymph nodes may give a
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Figure 2 A malignant (panel A) and a benign (panel B)
lymph node at Naruke level 7 (N7) on EUS, between the
left atrium (LA) and the right pulmonary artery (RPA).
Figure 3 A normal (panel A) and enlarged (panel B) left
adrenal gland (A) on EUS, on top of the left kidney (K).
Technical description of endoscopic ultrasound 181suggestion of malignancy. Lymph nodes are
suspicious for malignancy when they have a
hypoechoic structure, sharp edges, and a round
shape (Fig. 2A).9–11 Benign lymph nodes are
hyperechoic (representing fat) sometimes with
central calcification (indicating old granulomatous
disease), with unclear edges and a long, narrow,
draped, or triangular shape (Fig. 2B).10 The adrenal
gland is adjacent to the kidney, and it normally has
an iso- or hypoechoic appearance, with a triangu-
lar, elliptical, or ‘‘seagull’’ shape, not exceeding
3 cm in length (Fig. 3A).12,13 A suspicious adrenal
gland is larger than 3 cm and will loose its particular
shape, becoming round and more hypoechoic
(Fig. 3B).Endoscopic ultrasound imaging
Before the procedure, all equipment is installed.
When a balloon is used, it should be checked
whether the balloon is water-filled and free of air.
For the largest overview, the scanner unit is tunedto 5MHz and at a minimum of image zoom. For
detailed images, the scanner unit should be
switched to 7.5MHz to enhance resolution.
The procedure is typically performed in an
outpatient setting after at least 5 h of fasting. Five
ml of lidocaine-HCl 20mg/ml oral gel is adminis-
tered orally for local pharyngeal anesthesia. Mid-
azolam 2–5mg is administered intravenously for
conscious sedation, except for those patients who
are prone to suffer ventilatory depression. The
patient is monitored continuously on oxygen sa-
turation and pulse. The patient is placed in left
lateral decubitus position. After deflecting the tip
of the endoscope 70–80 vertically by turning the
larger button counterclockwise, the endoscope is
introduced in the oropharynx by placing the
ultrasound tip on the back of the tongue. Tension
on the larger button is then released, and the
endoscope is inserted into the esophagus while the
patient is swallowing. The endoscope is advanced
into the stomach. The lower esophageal sphincter
is located approximately 45–55 cm from the in-
cisors. Inside the stomach, the balloon may be filled
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Figure 5 Typical EUS appearance of spleen (panel A) and
liver (panel B).
H. Kramer et al.182with water. With a counterclockwise turn of the
larger button, the ultrasound tip will be pressed
against the gastric wall. With axial rotating move-
ments the abdominal aorta can be looked for,
projecting as a hypoechoic band. Using the aorta as
a guide, the celiac trunk and the superior mesen-
teric artery will be imaged by slightly advancing or
retracting the endoscope (Fig. 4). Enlarged lymph
nodes may be observed cranial to the celiac trunk.
Subsequently, the left kidney is imaged with a
clockwise movement of the endoscope (Fig. 3). By
gently retracting the endoscope, the left adrenal
gland is exposed at the kidney’s top, and can be
assessed for size, shape, and structure (Fig. 3). If
abnormal, FNA is performed. Parts of the liver,
spleen, and pancreas are observed by EUS–FNA as
well. Spleen and liver have characteristic ultra-
sound appearances (Fig. 5). We only assess the
ultrasonographically visible parts of the liver for
lesions since EUS is inadequate for assessment of
the entire liver for metastases. The right adrenal
gland may be observed only if the endoscope is put
through the pylorus.12 We only perform this
procedure on indication. Right adrenal enlarge-
ment is often assessed with transabdominal ultra-
sonography.
After assessment of the left adrenal gland, the
endoscope is retracted until its ultrasound device
lies in the distal esophagus, which can be observed
via the luminal video camera and the ultrasono-
graphic view of the beating heart. When used and
inflated, it may be necessary to deflate the balloon
before retracting the endoscope into the esopha-
gus. Behind the heart, possible lymph nodes at
Naruke level 9 are looked for by rotating the
endoscope 180 up to the aorta, both clockwise andFigure 4 Image of the celiac trunk (C) on EUS, above the
superior mesenteric artery (M) and anterior to the
abdominal aorta (AO), which is used for orientation when
approaching retroperitoneal lymph nodes.counterclockwise. The diaphragm will be observed
as a hyperechoic band below the heart.
The endoscope is retracted in steps of 1–2 cm,
and after each step a 360 view is performed, until
the pulmonary arteries come into view. Lymph
nodes adjacent to the esophageal wall above
Naruke level 9, adjacent to the atria of the heart,
are classified as Naruke level 8. Naruke level 7
(subcarinal) lymph nodes are typically located on
top of the left cardiac atrium, close to the right
pulmonary artery (Fig. 2). Especially the posterior
part of Naruke level 7, which is difficult to assess
with mediastinoscopy, can easily be viewed and
punctured for aspiration cytology. Parts of the
heart (such as the aortic and pulmonary roots, and
the aortic and mitral valves) can be viewed in
detail.
With a 360 movement both hila can be imaged.
Scattering occurs due to air in the trachea or main
bronchi. With slight counterclockwise movement,
the left pulmonary artery can be followed towards
the left hilum. After a 2–3 cm retraction, the left
tracheobronchial angle (Naruke level 4-left) and
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Figure 6 EUS image of the aortopulmonary window, lying
between aortic arch (AO) and left pulmonary artery
(LPA). Naruke levels 4-left (N4L, with needle inside), 5
(N5), and 6 (N6) are shown.
Technical description of endoscopic ultrasound 183the aortopulmonary window (Naruke level 5) come
into view (Fig. 6). Naruke level 4-left is located
immediately adjacent to the esophagus, while
Naruke level 5 projects more peripherally under
the aorta. Para-aortic lymph nodes (Naruke level 6)
can sometimes be seen in this view, located on the
outer side of the aortic arch (Fig. 6). This makes
FNA of Naruke level 6 from the esophagus often
difficult or even impossible. Rotating the endo-
scope 180 clockwise and counterclockwise, the
rest of the mediastinum is assessed, including the
right tracheobronchial angle (Naruke level 4-right).
To view around the air-filled trachea, it will be
necessary to bend the endoscope’s tip with both
the larger and smaller buttons in 2 dimensions.
Nonetheless, right-sided abnormalities are difficult
to image due to scatter from the air-filled trachea.
After this, the endoscope is rotated back to the
aortopulmonary window. With the aortic arch in
view, the endoscope is retracted until the area
above the aortic arch can be imaged. In this area,
the upper paratracheal lymph nodes (Naruke level
2-left) are located. After a 180 rotation, the right
paratracheal lymph nodes (Naruke level 2-right)
can occasionally be viewed.
At these upper lymph node levels, the patient is
likely to feel uncomfortable because of regurgita-
tion or coughing reflex. This makes imaging
followed by FNA of the paratracheal lymph nodes
difficult. Imaging of the upper mediastinal and
pretracheal lymph nodes (Naruke levels 1 and 3)
from the esophagus is not possible under conscious
sedation; cervical mediastinoscopy is more appro-
priate for these lymph node levels.
After assessment of lymph node levels, a decision
should be made to perform FNA on particular lymphnodes (see below). Apart from enlarged or other-
wise abnormal lymph nodes, direct ingrowth of
tumor into mediastinal structures such as the aorta
or the pulmonary artery can sometimes be seen,
and discrimination between T3 and T4 status is
possible.
After all observations and fine-needle aspirations
have been performed, the balloon is deflated
completely, and the endoscope is removed. The
patient is transferred to the recovery room to
recover from sedation, and is discharged after
approximately 1 h. The patient may eat and drink
approximately 2 h after administration of the
pharyngeal anesthesia. Mean duration of the
procedure (including FNA) is approximately
45–60min.Fine-needle aspiration
A lymph node or tumor is selected for FNA on the
basis of its malignant appearance and the feasi-
bility of FNA in relation to surrounding vital
structures. It may be important to puncture normal
lymph nodes around abnormal structures to assess
the stage of disease or even the resectability of a
very proximal located tumor. It is recommended to
puncture at least abnormalities on each level that
may alter clinical tumor stage.
For FNA, the needle with stylet is introduced into
the working channel of the endoscope. For the last
few centimeters of the introduction, tension is
released from the endoscope buttons to prevent
laceration of the inner lining of the working
channel. Tension on the buttons can be re-adjusted
after the needle has been introduced completely.
After the optimal punction site has been identified,
the distance from the needle exit to the lymph
node center is measured on screen, and the needle
stopper on the needle shaft is set to this distance.
The needle is then introduced into the mediasti-
num. After slight retraction of the stylet, the lymph
node is punctured (Fig. 6). The stylet is now
completely removed, and suction is applied with a
10-cc syringe. After 15–20 up-and-down move-
ments of the needle inside the lymph node
observed real-time on the monitor, the syringe is
closed and the needle is retracted and removed
from the endoscope. The specimen is put on a glass
slide, stained with a modified Giemsa method, and
evaluated on its cellularity by an attending
cytotechnician. If the yield is inadequate, addi-
tional punctures can be performed. In case of too
many erythrocytes in the specimen, the next
puncture may be performed without suction.
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EUS is performed with radial or linear scanning
ultrasound endoscopes. Radial scanning endoscopes
produce transaxial CT-like images, which can be
interpreted more easily. The more recently devel-
oped linear scanning endoscopes produce sagittal
images, making anatomical interpretation some-
what more difficult. However, linear FNA is safer
and more accurate than radial FNA because the
needle is visible during the entire procedure.14 As
described, a balloon is placed around the ultra-
sound tip, but the EUS–FNA procedure may also be
performed without a balloon. The tip is then
pushed against the esophageal or gastric wall. In
our experience, this does not influence the sensi-
tivity of the procedure.
Various needle types and sizes are in use, but no
significant differences in accuracy have been
reported in a study with four brands of needles.15
Suction can be applied with a syringe of 10, 20, or
30ml. Cellularity and quality of the FNA specimen
seems to be better with a 10ml syringe than with
one of 20 or 30ml.16 On the other hand, without
suction less blood will be aspirated, and this seems
favorable when an earlier punction contained too
many erythrocytes.
Key question is which lymph nodes have to be
aspirated, and which not. Using ultrasound appear-
ance properties as outlined above, some investiga-
tors have reached accuracies of 0.72–0.96, with a
large range in sensitivities and specificities.5,9,17 It
is clear that large lymph nodes may be benign and
contain inflammatory cells, while small lymph
nodes may be affected by micrometastasis. It is
therefore necessary to perform FNA on each
observed lymph node that may alter clinical tumor
stage, starting with the lymph node most distant to
the primary lung abnormality. A new needle should
be used for every lymph node station. Debate is
ongoing about whether an on-site cytopathologist is
necessary for adequate FNA specimen assess-
ment.18,19 A trained cytotechnician is present at
our EUS–FNA procedures, to indicate whether
cellularity of the specimen is adequate. In our
opinion, this prevents unnecessary additional punc-
tions or too early termination with inconclusive
results. Full cytological assessment is performed by
a cytopathologist afterwards.
Not all mediastinal lymph nodes can be imaged
with EUS, due to air in the larger airways.20 Lymph
nodes at Naruke levels 1, 2-right, 3, and 4-right are
generally difficult to assess.18,19 However, in our
experience apparently enlarged lymph nodes on
these levels may be visible and may be punctured
as well. Smaller lymph nodes on these levels maybetter be assessed with cervical mediastinoscopy.
The left adrenal gland can usually be evaluated
adequately. However, the right adrenal gland can
only be imaged with EUS by crossing the pylorus.
This is unpleasant for the patient and the right
adrenal gland is also much more difficult to
evaluate due to its location.
With more than 150 EUS–FNA procedures per-
formed, we did not encounter EUS–FNA-related
morbidity or mortality. In a prospective study on
EUS–FNA associated side-effects including 842
mediastinal EUS–FNA procedures, 4 minor compli-
cations (infection, hemorrhage, inexplicable
transient hypotension) were reported.21 Contra-
indications for EUS–FNA include increased bleeding
tendency and Zenker’s diverticulum.22 FNA should
not be performed on cystic lesions, because of risk
of infection.10 It seems wise to administer prophy-
lactic antibiotics in patients with implants or
generally increased infection risks.
In conclusion, we described the EUS–FNA proce-
dure for the mediastinal and retroperitoneal sta-
ging of lung cancer, with landmarks for adequate
orientation. With EUS–FNA, anatomical areas can
be reached that are inaccessible for cervical
mediastinoscopy. This makes EUS–FNA very con-
venient for the staging of lung cancer or the
assessment and diagnosis of any abnormality in
the posterior mediastinum. It offers great oppor-
tunities for endoscopists such as pulmonary physi-
cians.Acknowledgements
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